echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > Henreofazole Pali capsules, Malay acid pyridine tablets receive dispreced clinical trial notice

    Henreofazole Pali capsules, Malay acid pyridine tablets receive dispreced clinical trial notice

    • Last Update: 2020-05-14
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    According to the bulletin, fluorozole is a polyadenosine diphosphate nucleopolymerase (ADP-ribose polymerase, PARP) inhibitor that specifically kills tumor cells with BRCA mutationsFluoroporopoli capsules have been included in the priority review varieties by the Drug Review Center of the State Drug Administration and are intended to be used to treat recurrent ovarian cancer stoicwithwithwithwithd brcA1/2 pathogenic or suspected pathogenic mutations that have undergone second-line and above chemotherapy, fluoroopaly has similar products abroad oraparli (product name Lynparza), Luca Pali (commodity name Rubraca), Nirapali (trade name Zejula) and his prazolipali (commodity name
    According to the announcement,so far, the product has invested in research and development costs of about 77.878 million yuanSource: Hengrui Pharmaceutical Bulletin
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.